Shaohua Li
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dynamic phenotyping of radioiodine-refractory differentiated thyroid cancer: thyroglobulin trajectories, dual-modal imaging, and genotype-defined treatment resistance.
Journal: Frontiers in endocrinology
Published: May 26, 2026
Non-invasive detection of metastatic papillary thyroid carcinoma after radical surgery using salivary metabolomic biomarkers.
Journal: Archives of endocrinology and metabolism
Published: February 26, 2026
TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer.
Journal: Scientific reports
Published: March 21, 2024
Cervical lymph node metastasis prediction of postoperative papillary thyroid carcinoma before 131I therapy based on clinical and ultrasound characteristics.
Journal: Frontiers in endocrinology
Published: December 13, 2022
Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC).
Journal: Endocrine
Published: February 26, 2022
Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer.
Journal: Frontiers in oncology
Published: February 08, 2022
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial.
Journal: JAMA oncology
Published: December 16, 2021
Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy.
Journal: Nuclear medicine and biology
Published: February 16, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026